Journal of Evidence-Based Medicine 2012 Issue 3 xin xi dong tai

Home | Survey | Payment| Talks & Presentations | Job Opportunities

Journals A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Journal of Evidence-Based Medicine
1671-5144
2012 Issue 3

xin xi dong tai

..............page:129-133,179,188

A Survey of Clinicians' Cognition and Practice of Evidence-Based Medicine
DONG Shan;DONG Xiao-mei;PENG Lin;WANG Chang;DAI Jin-fang;WANG Sheng-yong

..............page:175-179

To Undergo Self-Imposed Hardships, and Hide One's Capacities and Bide One's Time: Breast Cancer Antiangiogenesis Targeted Therapy
liao ning

..............page:134-137

Differential Diagnosis of Multiple Hepatic Nodules in a Long-Term Survivor Child with Hepatoblastoma
guang dong sheng ren min yi yuan zhong liu zhong xin ; lin yu deng ; zong zuo ; liu hui

..............page:189-192

Tension-Free Repair Versus Traditional Herniorrhaphy in Strangulated Inguinal Hernia: A Meta-Analysis
li jun ; kang zhong qiang

..............page:169-174

Safety and Efficacy in First-Line Bevacizumab plus Taxane-Based Chemotherapy for Locally Recurrent or Metastatic Breast Cancer
ZHANG Pin;WEN Ling-zhu

..............page:147-149

Effect of Health Education Pathways on Diabetics:A Meta-Analysis
WANG Run-juan;ZHUO Qiang;ZHAO Qing-hua

..............page:180-184

RIBBON-2:Evaluating the Efficacy and Safety of Bevacizumab in Combination with Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
WANG Xiao-jia;QIAN Xue-ke

..............page:153-156

Diagnostic Value of Serum HE4 in Ovarian Tumors: A Meta Analysis
luo zhao qin ; li li

..............page:163-168

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
ZHANG Jin;GUO Zi-bai

..............page:141-143

Chemotherapy with Bevacizumab for First-Line Treatment of HER2 Negative Metastatic Breast Cancer
LIU Jian;LI Xue-rui

..............page:150-152,156

Phase Ⅲ Study of Bevacizumab plus Docetaxel Compared with Placebo plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
mao xiao yun ; jin feng ; wang kun

..............page:144-146

Efficacy and Safety of Ustekinumab for Plaque Psoriasis: A Meta-Analysis
YANG Hui-fang;WANG Qun

..............page:157-162

Treatment-Related Mortality with Bevacizumab in Cancer Patients
ZHANG Qing-yuan;REN Chong-yang

..............page:138-140

Network Meta-Analysis and Its Solution by R
ZHANG Tian-song;XIONG Qian

..............page:185-188